Afya (AFYA) got here out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.32 per share a 12 months in the past. These figures are adjusted for non-recurring objects.
This quarterly report represents an earnings shock of +18.75%. 1 / 4 in the past, it was anticipated that this medical training firm would submit earnings of $0.4 per share when it really produced earnings of $0.4, delivering no shock.
Over the past 4 quarters, the corporate has surpassed consensus EPS estimates thrice.
Afya, which belongs to the Zacks Faculties trade, posted revenues of $170.44 million for the quarter ended September 2025, lacking the Zacks Consensus Estimate by 0.16%. This compares to year-ago revenues of $151.71 million. The corporate has topped consensus income estimates two occasions during the last 4 quarters.
The sustainability of the inventory’s quick value motion primarily based on the recently-released numbers and future earnings expectations will largely rely on administration’s commentary on the earnings name.
Afya shares have misplaced about 9.1% because the starting of the 12 months versus the S&P 500’s achieve of 16.4%.
What’s Subsequent for Afya?
Whereas Afya has underperformed the market to date this 12 months, the query that involves buyers’ minds is: what’s subsequent for the inventory?
There are not any straightforward solutions to this key query, however one dependable measure that may assist buyers tackle that is the corporate’s earnings outlook. Not solely does this embody present consensus earnings expectations for the approaching quarter(s), but in addition how these expectations have modified currently.
Empirical analysis exhibits a powerful correlation between near-term inventory actions and traits in earnings estimate revisions. Traders can observe such revisions by themselves or depend on a tried-and-tested ranking instrument just like the Zacks Rank, which has a formidable observe document of harnessing the facility of earnings estimate revisions.
Forward of this earnings launch, the estimate revisions pattern for Afya was blended. Whereas the magnitude and course of estimate revisions might change following the corporate’s just-released earnings report, the present standing interprets right into a Zacks Rank #3 (Maintain) for the inventory. So, the shares are anticipated to carry out according to the market within the close to future. You possibly can see the whole record of as we speak’s Zacks #1 Rank (Robust Purchase) shares right here.
Will probably be fascinating to see how estimates for the approaching quarters and the present fiscal 12 months change within the days forward. The present consensus EPS estimate is $0.40 on $172.53 million in revenues for the approaching quarter and $1.71 on $687.12 million in revenues for the present fiscal 12 months.
Traders ought to be conscious of the truth that the outlook for the trade can have a cloth affect on the efficiency of the inventory as effectively. When it comes to the Zacks Trade Rank, Faculties is at the moment within the backside 32% of the 250 plus Zacks industries. Our analysis exhibits that the highest 50% of the Zacks-ranked industries outperform the underside 50% by an element of greater than 2 to 1.
One other inventory from the identical trade, Legacy Training Inc. (LGCY), has but to report outcomes for the quarter ended September 2025. The outcomes are anticipated to be launched on November 13.
This firm is anticipated to submit quarterly earnings of $0.15 per share in its upcoming report, which represents a year-over-year change of -28.6%. The consensus EPS estimate for the quarter has remained unchanged during the last 30 days.
Legacy Training Inc.’s revenues are anticipated to be $18.34 million, up 30.9% from the year-ago quarter.
Ought to You Spend money on Afya Restricted (AFYA)?
Earlier than you put money into Afya Restricted (AFYA), need to know one of the best shares to purchase for the subsequent 30 days? Try Zacks Funding Analysis for our free report on the 7 finest shares to purchase.
Zacks Funding Analysis has been dedicated to offering buyers with instruments and impartial analysis since 1978. For greater than 1 / 4 century, the Zacks Rank stock-rating system has greater than doubled the S&P 500 with a mean achieve of +24.08% per 12 months. (These returns cowl a interval from January 1, 1988 by Might 6, 2024.)
Afya Restricted (AFYA) : Free Inventory Evaluation Report
Legacy Training Inc. (LGCY) : Free Inventory Evaluation Report
This text initially printed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
